Is SONX or TMDIF more profitable?

Titan Medical has a net margin of 0.00% compared to Sonendo's net margin of -92.74%. Titan Medical's return on equity of -82.31% beat Sonendo's return on equity. Company Net Margins Return on Equity Return on Assets Sonendo -92.74% -184.01% -68.60% Titan Medical N/A -82.31% -51.47%

Do analysts rate SONX or ICU?

SeaStar Medical has a consensus target price of $8.00, indicating a potential upside of 174.91%. Given SeaStar Medical's stronger consensus rating and higher probable upside, analysts plainly believe SeaStar Medical is more favorable than Sonendo. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sonendo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SeaStar Medical 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Is SONX or ICU more profitable?

Sonendo has a net margin of -92.74% compared to SeaStar Medical's net margin of -795.51%. SeaStar Medical's return on equity of -162.75% beat Sonendo's return on equity. Company Net Margins Return on Equity Return on Assets Sonendo -92.74% -184.01% -68.60% SeaStar Medical -795.51% -162.75% -109.89%

Do analysts rate IRIX or SONX?

IRIDEX currently has a consensus price target of $3.00, suggesting a potential upside of 328.14%. Given IRIDEX's stronger consensus rating and higher possible upside, analysts clearly believe IRIDEX is more favorable than Sonendo. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score IRIDEX 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Sonendo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has stronger earnings and valuation, IRIX or SONX?

IRIDEX has higher revenue and earnings than Sonendo. IRIDEX is trading at a lower price-to-earnings ratio than Sonendo, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio IRIDEX $52.67M 0.23 -$4.44M -$0.20 N/A Sonendo $44.40M 0.13 -$60.92M -$71.12 N/A

Is IRIX or SONX more profitable?

IRIDEX has a net margin of -6.88% compared to Sonendo's net margin of -92.74%. IRIDEX's return on equity of 0.00% beat Sonendo's return on equity. Company Net Margins Return on Equity Return on Assets IRIDEX -6.88% N/A -12.55% Sonendo -92.74% -184.01% -68.60%

Do analysts rate HSCS or SONX?

HeartSciences currently has a consensus target price of $8.00, suggesting a potential upside of 138.10%. Given HeartSciences' stronger consensus rating and higher possible upside, equities research analysts clearly believe HeartSciences is more favorable than Sonendo. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score HeartSciences 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Sonendo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Is HSCS or SONX more profitable?

HeartSciences has a net margin of 0.00% compared to Sonendo's net margin of -92.74%. Sonendo's return on equity of -184.01% beat HeartSciences' return on equity. Company Net Margins Return on Equity Return on Assets HeartSciences N/A -358.60% -144.82% Sonendo -92.74% -184.01% -68.60%

Sonendo (SONX) Competitors

$1.20 0.00 (0.00%)

As of 09/2/2026

Compare

SONX vs. NMTC, TMDIF, ICU, IRIX, and HSCS

Should you buy Sonendo stock or one of its competitors? Sonendo's main competitors and comparable companies include NeuroOne Medical Technologies (NMTC), Titan Medical (TMDIF), SeaStar Medical (ICU), IRIDEX (IRIX), and HeartSciences (HSCS). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Sonendo compare to NeuroOne Medical Technologies?

NeuroOne Medical Technologies (NASDAQ:NMTC) and Sonendo (NYSE:SONX) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, media sentiment, analyst recommendations, risk, dividends and valuation.

In the previous week, NeuroOne Medical Technologies had 1 more articles in the media than Sonendo. MarketBeat recorded 1 mentions for NeuroOne Medical Technologies and 0 mentions for Sonendo. NeuroOne Medical Technologies' average media sentiment score of 0.39 beat Sonendo's score of 0.00 indicating that NeuroOne Medical Technologies is being referred to more favorably in the media.

Company	Overall Sentiment
NeuroOne Medical Technologies	Neutral
Sonendo	Neutral

NeuroOne Medical Technologies has a beta of 0.65, meaning that its stock price is 35% less volatile than the broader market. Comparatively, Sonendo has a beta of 1.8, meaning that its stock price is 80% more volatile than the broader market.

NeuroOne Medical Technologies has higher earnings, but lower revenue than Sonendo. NeuroOne Medical Technologies is trading at a lower price-to-earnings ratio than Sonendo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NeuroOne Medical Technologies	$12.10M	1.25	-$3.61M	-$0.95	N/A
Sonendo	$44.40M	0.13	-$60.92M	-$71.12	N/A

16.1% of NeuroOne Medical Technologies shares are held by institutional investors. Comparatively, 28.7% of Sonendo shares are held by institutional investors. 11.8% of NeuroOne Medical Technologies shares are held by company insiders. Comparatively, 7.9% of Sonendo shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

NeuroOne Medical Technologies presently has a consensus target price of $7.33, suggesting a potential upside of 341.77%. Given NeuroOne Medical Technologies' stronger consensus rating and higher probable upside, equities analysts plainly believe NeuroOne Medical Technologies is more favorable than Sonendo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NeuroOne Medical Technologies	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Sonendo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

NeuroOne Medical Technologies has a net margin of -71.50% compared to Sonendo's net margin of -92.74%. NeuroOne Medical Technologies' return on equity of -128.12% beat Sonendo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NeuroOne Medical Technologies	-71.50%	-128.12%	-86.34%
Sonendo	-92.74%	-184.01%	-68.60%

Summary

NeuroOne Medical Technologies beats Sonendo on 11 of the 16 factors compared between the two stocks.

How does Sonendo compare to Titan Medical?

Sonendo (NYSE:SONX) and Titan Medical (NASDAQ:TMDIF) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their risk, dividends, earnings, profitability, valuation, analyst recommendations, media sentiment and institutional ownership.

Titan Medical has a net margin of 0.00% compared to Sonendo's net margin of -92.74%. Titan Medical's return on equity of -82.31% beat Sonendo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sonendo	-92.74%	-184.01%	-68.60%
Titan Medical	N/A	-82.31%	-51.47%

In the previous week, Sonendo's average media sentiment score of 0.00 equaled Titan Medical'saverage media sentiment score.

Company	Overall Sentiment
Sonendo	Neutral
Titan Medical	Neutral

Titan Medical has lower revenue, but higher earnings than Sonendo. Sonendo is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sonendo	$44.40M	0.13	-$60.92M	-$71.12	N/A
Titan Medical	$17.63M	0.85	$6.95M	$0.05	2.64

Sonendo has a beta of 1.8, indicating that its share price is 80% more volatile than the broader market. Comparatively, Titan Medical has a beta of 1.26, indicating that its share price is 26% more volatile than the broader market.

28.7% of Sonendo shares are held by institutional investors. Comparatively, 0.0% of Titan Medical shares are held by institutional investors. 7.9% of Sonendo shares are held by company insiders. Comparatively, 0.0% of Titan Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Titan Medical beats Sonendo on 6 of the 11 factors compared between the two stocks.

How does Sonendo compare to SeaStar Medical?

Sonendo (NYSE:SONX) and SeaStar Medical (NASDAQ:ICU) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, risk, earnings, media sentiment, dividends and valuation.

SeaStar Medical has lower revenue, but higher earnings than Sonendo. SeaStar Medical is trading at a lower price-to-earnings ratio than Sonendo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sonendo	$44.40M	0.13	-$60.92M	-$71.12	N/A
SeaStar Medical	$1.23M	10.43	-$12.15M	-$3.91	N/A

SeaStar Medical has a consensus target price of $8.00, indicating a potential upside of 174.91%. Given SeaStar Medical's stronger consensus rating and higher probable upside, analysts plainly believe SeaStar Medical is more favorable than Sonendo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sonendo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
SeaStar Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Sonendo has a net margin of -92.74% compared to SeaStar Medical's net margin of -795.51%. SeaStar Medical's return on equity of -162.75% beat Sonendo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sonendo	-92.74%	-184.01%	-68.60%
SeaStar Medical	-795.51%	-162.75%	-109.89%

28.7% of Sonendo shares are held by institutional investors. Comparatively, 1.7% of SeaStar Medical shares are held by institutional investors. 7.9% of Sonendo shares are held by company insiders. Comparatively, 0.7% of SeaStar Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Sonendo's average media sentiment score of 0.00 equaled SeaStar Medical'saverage media sentiment score.

Company	Overall Sentiment
Sonendo	Neutral
SeaStar Medical	Neutral

Sonendo has a beta of 1.8, meaning that its share price is 80% more volatile than the broader market. Comparatively, SeaStar Medical has a beta of -1.05, meaning that its share price is 205% less volatile than the broader market.

Summary

Sonendo and SeaStar Medical tied by winning 7 of the 14 factors compared between the two stocks.

How does Sonendo compare to IRIDEX?

IRIDEX (NASDAQ:IRIX) and Sonendo (NYSE:SONX) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their dividends, institutional ownership, profitability, media sentiment, analyst recommendations, earnings, valuation and risk.

IRIDEX has higher revenue and earnings than Sonendo. IRIDEX is trading at a lower price-to-earnings ratio than Sonendo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IRIDEX	$52.67M	0.23	-$4.44M	-$0.20	N/A
Sonendo	$44.40M	0.13	-$60.92M	-$71.12	N/A

IRIDEX currently has a consensus price target of $3.00, suggesting a potential upside of 328.14%. Given IRIDEX's stronger consensus rating and higher possible upside, analysts clearly believe IRIDEX is more favorable than Sonendo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IRIDEX	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Sonendo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

20.1% of IRIDEX shares are owned by institutional investors. Comparatively, 28.7% of Sonendo shares are owned by institutional investors. 8.6% of IRIDEX shares are owned by insiders. Comparatively, 7.9% of Sonendo shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

IRIDEX has a net margin of -6.88% compared to Sonendo's net margin of -92.74%. IRIDEX's return on equity of 0.00% beat Sonendo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IRIDEX	-6.88%	N/A	-12.55%
Sonendo	-92.74%	-184.01%	-68.60%

In the previous week, IRIDEX's average media sentiment score of 0.00 equaled Sonendo'saverage media sentiment score.

Company	Overall Sentiment
IRIDEX	Neutral
Sonendo	Neutral

IRIDEX has a beta of 0.62, suggesting that its share price is 38% less volatile than the broader market. Comparatively, Sonendo has a beta of 1.8, suggesting that its share price is 80% more volatile than the broader market.

Summary

IRIDEX beats Sonendo on 11 of the 14 factors compared between the two stocks.

How does Sonendo compare to HeartSciences?

HeartSciences (NASDAQ:HSCS) and Sonendo (NYSE:SONX) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, profitability, dividends, valuation, analyst recommendations, media sentiment, risk and earnings.

HeartSciences has a net margin of 0.00% compared to Sonendo's net margin of -92.74%. Sonendo's return on equity of -184.01% beat HeartSciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HeartSciences	N/A	-358.60%	-144.82%
Sonendo	-92.74%	-184.01%	-68.60%

17.2% of HeartSciences shares are held by institutional investors. Comparatively, 28.7% of Sonendo shares are held by institutional investors. 4.9% of HeartSciences shares are held by company insiders. Comparatively, 7.9% of Sonendo shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, HeartSciences had 1 more articles in the media than Sonendo. MarketBeat recorded 1 mentions for HeartSciences and 0 mentions for Sonendo. HeartSciences' average media sentiment score of 0.00 equaled Sonendo'saverage media sentiment score.

Company	Overall Sentiment
HeartSciences	Neutral
Sonendo	Neutral

HeartSciences has higher earnings, but lower revenue than Sonendo. HeartSciences is trading at a lower price-to-earnings ratio than Sonendo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HeartSciences	N/A	N/A	-$9.14M	-$3.94	N/A
Sonendo	$44.40M	0.13	-$60.92M	-$71.12	N/A

HeartSciences currently has a consensus target price of $8.00, suggesting a potential upside of 138.10%. Given HeartSciences' stronger consensus rating and higher possible upside, equities research analysts clearly believe HeartSciences is more favorable than Sonendo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HeartSciences	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Sonendo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

HeartSciences has a beta of 1.85, suggesting that its stock price is 85% more volatile than the broader market. Comparatively, Sonendo has a beta of 1.8, suggesting that its stock price is 80% more volatile than the broader market.

Summary

HeartSciences beats Sonendo on 8 of the 14 factors compared between the two stocks.

Get Sonendo News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SONX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SONX vs. The Competition

Export

Metric	Sonendo	Healthcare Equipment & Supplies Industry	Healthcare Sector	NYSE Exchange
Market Cap	$5.73M	$5.81B	$7.26B	$23.50B
Dividend Yield	N/A	1.76%	2.53%	3.73%
P/E Ratio	-0.02	25.93	273.28	29.39
Price / Sales	0.13	73.29	613.48	21.00
Price / Cash	N/A	33.14	77.82	32.15
Price / Book	0.01	6.04	12.89	7.63
Net Income	-$60.92M	$150.03M	$3.47B	$1.07B
7 Day Performance	20.00%	-1.30%	0.61%	-0.16%
1 Month Performance	N/A	1.29%	5.73%	-0.46%
1 Year Performance	N/A	9.89%	25.37%	13.09%

Sonendo Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SONX Sonendo	N/A	$1.20 flat	N/A	+2,976.9%	$5.73M	$44.40M	N/A	250
NMTC NeuroOne Medical Technologies	2.27 of 5 stars	$1.98 -1.0%	$7.33 +270.4%	-62.8%	$18.21M	$12.10M	N/A	20	High Trading Volume
TMDIF Titan Medical	N/A	$0.12 +6.0%	N/A	-60.8%	$13.97M	$17.63M	N/A	50
ICU SeaStar Medical	2.6743 of 5 stars	$3.10 -0.6%	$8.00 +158.1%	-66.3%	$13.75M	$1.71M	N/A	2
IRIX IRIDEX	1.6289 of 5 stars	$0.71 +0.7%	$3.00 +321.2%	-49.4%	$12.51M	$51.57M	N/A	120

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:SONX) was last updated on 9/4/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Sonendo (SONX) Competitors

SONX vs. NMTC, TMDIF, ICU, IRIX, and HSCS

How does Sonendo compare to NeuroOne Medical Technologies?

Summary

How does Sonendo compare to Titan Medical?

Summary

How does Sonendo compare to SeaStar Medical?

Summary

How does Sonendo compare to IRIDEX?

Summary

How does Sonendo compare to HeartSciences?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SONX vs. The Competition

Sonendo Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Sonendo (SONX) Competitors

SONX vs. NMTC, TMDIF, ICU, IRIX, and HSCS

How does Sonendo compare to NeuroOne Medical Technologies?

Does the media prefer NMTC or SONX?

Which has more volatility & risk, NMTC or SONX?

Which has preferable earnings and valuation, NMTC or SONX?

Do institutionals and insiders have more ownership in NMTC or SONX?

Do analysts recommend NMTC or SONX?

Is NMTC or SONX more profitable?

Summary

How does Sonendo compare to Titan Medical?

Is SONX or TMDIF more profitable?

Does the media refer more to SONX or TMDIF?

Which has higher earnings and valuation, SONX or TMDIF?

Which has more volatility & risk, SONX or TMDIF?

Do insiders & institutionals have more ownership in SONX or TMDIF?

Summary

How does Sonendo compare to SeaStar Medical?

Which has stronger valuation and earnings, SONX or ICU?

Do analysts rate SONX or ICU?

Is SONX or ICU more profitable?

Do insiders and institutionals believe in SONX or ICU?

Does the media refer more to SONX or ICU?

Which has more volatility and risk, SONX or ICU?

Summary

How does Sonendo compare to IRIDEX?

Which has stronger earnings and valuation, IRIX or SONX?

Do analysts rate IRIX or SONX?

Do institutionals and insiders have more ownership in IRIX or SONX?

Is IRIX or SONX more profitable?

Does the media prefer IRIX or SONX?

Which has more risk and volatility, IRIX or SONX?

Summary

How does Sonendo compare to HeartSciences?

Is HSCS or SONX more profitable?

Do insiders & institutionals have more ownership in HSCS or SONX?

Does the media favor HSCS or SONX?

Which has higher earnings & valuation, HSCS or SONX?

Do analysts rate HSCS or SONX?

Which has more risk & volatility, HSCS or SONX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SONX vs. The Competition

Sonendo Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools